| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A mixed‐methods study to evaluate a patient‐designed tool to reduce harm from cancer‐associated thrombosis: The EMPOWER study
|
Baddeley, Elin
|
|
|
|
5 |
p.
|
artikel
|
| 2 |
An illustrated review of bleeding assessment tools and common coagulation tests
|
Elbaz, Carolyne
|
|
|
|
5 |
p. 761-773
|
artikel
|
| 3 |
Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism
|
Carney, Brian J.
|
|
|
|
5 |
p. 860-865
|
artikel
|
| 4 |
Anticoagulation, immortality, and observations of COVID‐19
|
Maley, Jason H.
|
|
|
|
5 |
p. 674-676
|
artikel
|
| 5 |
Antiviral anticoagulation
|
Pryzdial, Edward L.G.
|
|
|
|
5 |
p. 774-788
|
artikel
|
| 6 |
A proposal for staging COVID‐19 coagulopathy
|
Thachil, Jecko
|
|
|
|
5 |
p. 731-736
|
artikel
|
| 7 |
A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn score
|
Norris, Lucy A.
|
|
|
|
5 |
p. 848-859
|
artikel
|
| 8 |
A tail of two ITAMs: GPVI/FcRγ and FcγRIIa's role in platelet activation and thrombus stability
|
Neeves, Keith B.
|
|
|
|
5 |
p.
|
artikel
|
| 9 |
Bleeding is increased in amyloid precursor protein knockout mouse
|
Mazinani, Nima
|
|
|
|
5 |
p. 823-828
|
artikel
|
| 10 |
Bleeding risks for uncharacterized platelet function disorders
|
Brunet, Justin
|
|
|
|
5 |
p. 799-806
|
artikel
|
| 11 |
Blood and Bone: The quarantine chronicles
|
Taylor, Kirk A.
|
|
|
|
5 |
p. 727-730
|
artikel
|
| 12 |
Coagulation markers and functional outcome in acute ischemic stroke: Impact of intensive versus standard hyperglycemia control
|
Gentile, Nina T.
|
|
|
|
5 |
p.
|
artikel
|
| 13 |
Colon cancer surgery in von Willebrand disease type 3 setting triggering vascular abnormalities on bowel anastomosis
|
Rauch, Antoine
|
|
|
|
5 |
p.
|
artikel
|
| 14 |
Comparison of 2 ways of performing ristocetin-induced platelet agglutination mixing study for diagnosis of type 2B von Willebrand disease. Response to the publication of Soleimani et al
|
Favaloro, Emmanuel J.
|
|
|
|
5 |
p.
|
artikel
|
| 15 |
Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases
|
Melicine, Sophie
|
|
|
|
5 |
p.
|
artikel
|
| 16 |
D‐dimer, thrombin generation, and risk of a first venous thrombosis in the elderly
|
Wang, Huijie
|
|
|
|
5 |
p.
|
artikel
|
| 17 |
Design strategy of antidote sequence for bivalent aptamer: Rapid neutralization of high‐anticoagulant thrombin‐binding bivalent DNA aptamer‐linked M08 with HD22
|
Yoshitomi, Toru
|
|
|
|
5 |
p.
|
artikel
|
| 18 |
Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy
|
Romano, Lorenzo G.R.
|
|
|
|
5 |
p.
|
artikel
|
| 19 |
Determination of von Willebrand factor level in patient with sickle cell diseasein vaso‐occlusive crisis
|
Akaba, Kingsley
|
|
|
|
5 |
p. 902-905
|
artikel
|
| 20 |
Development of inhibitors in hemophilia A: An illustrated review
|
Jardim, Letícia Lemos
|
|
|
|
5 |
p. 752-760
|
artikel
|
| 21 |
Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational study
|
Baker, Ross I.
|
|
|
|
5 |
p.
|
artikel
|
| 22 |
Editorial Board
|
|
|
|
|
5 |
p.
|
artikel
|
| 23 |
Effect of pH on thrombin activity measured by calibrated automated thrombinography
|
Jackson, Joseph W.
|
|
|
|
5 |
p. 944-945
|
artikel
|
| 24 |
Eltrombopag plus cyclosporine in refractory immune thrombocytopenia: a single-center study
|
Hong, Yilei
|
|
|
|
5 |
p.
|
artikel
|
| 25 |
Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single‐center report
|
Warren, Beth Boulden
|
|
|
|
5 |
p.
|
artikel
|
| 26 |
ERRATUM
|
|
|
|
|
5 |
p.
|
artikel
|
| 27 |
ERRATUM
|
|
|
|
|
5 |
p.
|
artikel
|
| 28 |
ERRATUM
|
|
|
|
|
5 |
p.
|
artikel
|
| 29 |
Erratum to ‘A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays.’ [Research and Practice in Thrombosis and Haemostasis Volume 7, Issue 3, March 2023, 100139]
|
Colpani, Paola
|
|
|
|
5 |
p.
|
artikel
|
| 30 |
Exercise social support, barriers, and instructions in venous thromboembolism survivors: a descriptive study
|
Partridge, Julie A.
|
|
|
|
5 |
p.
|
artikel
|
| 31 |
Exploring heterogeneity in reported venous thromboembolism risk in COVID-19 and comparison to other viral pneumonias: a systematic review and meta-regression
|
Bhoelan, Soerajja
|
|
|
|
5 |
p.
|
artikel
|
| 32 |
Fibrinogen BOE II: dysfibrinogenemia with bleeding and defective thrombin binding
|
Li, Yang
|
|
|
|
5 |
p.
|
artikel
|
| 33 |
Fibronectin binding to von Willebrand factor occurs via the A1 domain
|
Keesler, Daniel A.
|
|
|
|
5 |
p.
|
artikel
|
| 34 |
Gender gap in women authors is not worse during COVID‐19 pandemic: Results from Research and Practice in Thrombosis and Haemostasis
|
Cushman, Mary
|
|
|
|
5 |
p. 672-673
|
artikel
|
| 35 |
Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura
|
Kangro, Kadri
|
|
|
|
5 |
p. 918-930
|
artikel
|
| 36 |
Global reporting of pulmonary embolism–related deaths in the World Health Organization mortality database: Vital registration data from 123 countries
|
Barco, Stefano
|
|
|
|
5 |
p.
|
artikel
|
| 37 |
Hand grip strength in venous thromboembolism: risk of recurrence and mortality
|
Leknessund, Oda G.R.
|
|
|
|
5 |
p.
|
artikel
|
| 38 |
Health-related quality of life after first venous thromboembolism in individuals aged 70 years and older
|
Wang, Huijie
|
|
|
|
5 |
p.
|
artikel
|
| 39 |
Health‐related quality‐of‐life questionnaires for deep vein thrombosis and pulmonary embolism: A systematic review on questionnaire development and methodology
|
Asady, Elia
|
|
|
|
5 |
p.
|
artikel
|
| 40 |
Heparin-induced thrombocytopenia: An illustrated review
|
May, Jori
|
|
|
|
5 |
p.
|
artikel
|
| 41 |
Heparin‐induced thrombocytopenia in end‐stage renal disease: Reliability of the PF4‐heparin ELISA
|
Kelly, Julie
|
|
|
|
5 |
p.
|
artikel
|
| 42 |
Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome
|
Riker, Richard R.
|
|
|
|
5 |
p. 936-941
|
artikel
|
| 43 |
Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress
|
Ariens, Robert
|
|
|
|
5 |
p. 680-713
|
artikel
|
| 44 |
Illustrated State‐of‐the‐Art Capsules of the ISTH 2021 Congress
|
Krishnaswamy, Sriram
|
|
|
|
5 |
p.
|
artikel
|
| 45 |
Impact of an institutional grant award on early career investigator applicants and peer reviewers
|
Mughal, Amreen
|
|
|
|
5 |
p.
|
artikel
|
| 46 |
Improving preprocedure antithrombotic management: Implementation and sustainment of a best practice alert and pharmacist referral process
|
Han, Henry
|
|
|
|
5 |
p.
|
artikel
|
| 47 |
In vitro characterization of CT‐001—a short‐acting factor VIIa with enhanced prohemostatic activity
|
Sim, Derek S.
|
|
|
|
5 |
p.
|
artikel
|
| 48 |
ISSUE INFORMATION
|
|
|
|
|
5 |
p. 667-671
|
artikel
|
| 49 |
Issue Information
|
|
|
|
|
5 |
p.
|
artikel
|
| 50 |
Issue Information
|
|
|
|
|
5 |
p.
|
artikel
|
| 51 |
Journal impact factor: Recent evaluation changes and Research and Practice in Thrombosis and Haemostasis
|
Coughlin, Brian
|
|
|
|
5 |
p.
|
artikel
|
| 52 |
Laboratory diagnosis of von Willebrand disease in the age of the new guidelines: considerations based on geography and resources
|
Favaloro, Emmanuel J.
|
|
|
|
5 |
p.
|
artikel
|
| 53 |
Letter in response to Colpani et al “A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays”
|
Favaloro, Emmanuel J.
|
|
|
|
5 |
p.
|
artikel
|
| 54 |
Liver fibrosis is driven by protease‐activated receptor‐1 expressed by hepatic stellate cells in experimental chronic liver injury
|
Poole, Lauren G.
|
|
|
|
5 |
p. 906-917
|
artikel
|
| 55 |
Living with a “hemophilia‐free mind” – The new ambition of hemophilia care?
|
Krumb, Evelien
|
|
|
|
5 |
p.
|
artikel
|
| 56 |
Long-term mortality in patients with pulmonary embolism: results in a single-center registry
|
Eckelt, Johannes
|
|
|
|
5 |
p.
|
artikel
|
| 57 |
Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors
|
Li, Zekun
|
|
|
|
5 |
p.
|
artikel
|
| 58 |
Measuring beta‐galactose exposure on platelets: Standardization and healthy reference values
|
Lasne, Dominique
|
|
|
|
5 |
p. 813-822
|
artikel
|
| 59 |
Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
|
Samuelson Bannow, Bethany
|
|
|
|
5 |
p.
|
artikel
|
| 60 |
Monocyte activation and acquired autoimmune protein S deficiency promote disseminated intravascular coagulation in a patient with primary antiphospholipid syndrome
|
Beckmann, Lennart
|
|
|
|
5 |
p.
|
artikel
|
| 61 |
Musculoskeletal ultrasound in hemophilia: Results and recommendations from a global survey and consensus meeting
|
Bakeer, Nihal
|
|
|
|
5 |
p.
|
artikel
|
| 62 |
N‐Methyl‐3,4‐methylendioxymethamphetamine (MDMA)‐related coagulopathy and rhabdomyolysis: A case series and literature review
|
Doyle, Andrew J.
|
|
|
|
5 |
p. 829-834
|
artikel
|
| 63 |
N‐Terminal pro‐B‐type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort
|
Judd, Suzanne E.
|
|
|
|
5 |
p. 893-901
|
artikel
|
| 64 |
Physical forces regulating hemostasis and thrombosis: Vessels, cells, and molecules in illustrated review
|
Lin, Jessica
|
|
|
|
5 |
p.
|
artikel
|
| 65 |
Plasma‐derived factor X concentrate compassionate use for hereditary factor X deficiency: Long‐term safety and efficacy in a retrospective data‐collection study
|
Huang, James N.
|
|
|
|
5 |
p.
|
artikel
|
| 66 |
Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability
|
Mitchell, Joanne L.
|
|
|
|
5 |
p.
|
artikel
|
| 67 |
Podoplanin and CLEC-2 levels in patients with COVID-19
|
Borba-Junior, Ivanio Teixeira
|
|
|
|
5 |
p.
|
artikel
|
| 68 |
Post‐discharge thrombosis and bleeding in medical patients: A novel risk score derived from ubiquitous biomarkers
|
Woller, Scott C.
|
|
|
|
5 |
p.
|
artikel
|
| 69 |
Potential role of platelets in COVID‐19: Implications for thrombosis
|
Koupenova, Milka
|
|
|
|
5 |
p. 737-740
|
artikel
|
| 70 |
Predicting postdischarge hospital‐associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkers
|
Snyder, Lindsey
|
|
|
|
5 |
p. 872-878
|
artikel
|
| 71 |
Protease: Serpin complexes to assess contact system and intrinsic pathway activation
|
Henderson, Michael W.
|
|
|
|
5 |
p. 789-798
|
artikel
|
| 72 |
Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?
|
Shaw, Joseph R.
|
|
|
|
5 |
p. 677-679
|
artikel
|
| 73 |
Pulmonary embolism and deep venous thrombosis after COVID-19: long-term risk in a population-based cohort study
|
Sjöland, Helen
|
|
|
|
5 |
p.
|
artikel
|
| 74 |
Pulmonary embolism during the COVID‐19 pandemic: Decline in diagnostic procedures and incidence at a university hospital
|
Nopp, Stephan
|
|
|
|
5 |
p. 835-841
|
artikel
|
| 75 |
Pulmonary embolism in acute lymphoblastic leukemia — An observational study of 1685 patients treated according to the NOPHO ALL2008 protocol
|
Tuckuviene, Ruta
|
|
|
|
5 |
p. 866-871
|
artikel
|
| 76 |
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
|
Bavalia, Roisin
|
|
|
|
5 |
p.
|
artikel
|
| 77 |
Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children’s Hospital-Acquired Thrombosis Consortium
|
Wilson, Hope P.
|
|
|
|
5 |
p.
|
artikel
|
| 78 |
Respective roles of Glycoprotein VI and FcγRIIA in the regulation of αIIbβ3‐mediated platelet activation to fibrinogen, thrombus buildup, and stability
|
Ahmed, Muhammad Usman
|
|
|
|
5 |
p.
|
artikel
|
| 79 |
Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial
|
Mones, Jodi V.
|
|
|
|
5 |
p.
|
artikel
|
| 80 |
Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in China
|
Zhou, Hu
|
|
|
|
5 |
p.
|
artikel
|
| 81 |
Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals
|
Abdulrehman, Jameel
|
|
|
|
5 |
p.
|
artikel
|
| 82 |
Serotonin secretion by blood platelets: accuracy of high-performance liquid chromatography-electrochemical technique compared with the isotopic test and use in a clinical laboratory
|
Aranda, Eduardo
|
|
|
|
5 |
p.
|
artikel
|
| 83 |
Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features
|
Cheloff, Abraham Z.
|
|
|
|
5 |
p. 807-812
|
artikel
|
| 84 |
Sex differences in flow cytometry–based platelet reactivity in stable outpatients suspected of myocardial ischemia
|
Waissi, Farahnaz
|
|
|
|
5 |
p. 879-885
|
artikel
|
| 85 |
Staying updated on COVID‐19: Social media to amplify science in thrombosis and hemostasis
|
Makris, Mike
|
|
|
|
5 |
p. 722-726
|
artikel
|
| 86 |
The Edoxaban Hokusai VTE PEDIATRICS Study: An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease
|
van Ommen, Cornelia Heleen
|
|
|
|
5 |
p. 886-892
|
artikel
|
| 87 |
The effect of emicizumab and bypassing agents in patients with hemophilia – An in vitro study
|
Schultz, Nina Haagenrud
|
|
|
|
5 |
p.
|
artikel
|
| 88 |
The odds and implications of coinheritance of hemophilia A and B
|
Karch, Corinne
|
|
|
|
5 |
p. 931-935
|
artikel
|
| 89 |
The underrecognized prothrombotic vascular disease of COVID‐19
|
Cohoon, Kevin P.
|
|
|
|
5 |
p. 942-943
|
artikel
|
| 90 |
Thrombosis and coagulopathy in COVID‐19: An illustrated review
|
Levi, Marcel
|
|
|
|
5 |
p. 744-751
|
artikel
|
| 91 |
Thrombosis and thromboembolism related to COVID‐19: A clarion call for obtaining solid estimates from large‐scale multicenter data
|
Barco, Stefano
|
|
|
|
5 |
p. 741-743
|
artikel
|
| 92 |
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry
|
Griffee, Matthew J.
|
|
|
|
5 |
p.
|
artikel
|
| 93 |
Thrombotic potential during pediatric acute lymphoblastic leukemia induction: Role of cell‐free DNA
|
Kumar, Rahul
|
|
|
|
5 |
p.
|
artikel
|
| 94 |
Tranexamic acid evidence and controversies: An illustrated review
|
Relke, Nicole
|
|
|
|
5 |
p.
|
artikel
|
| 95 |
Use of rotational thromboelastometry to predict hemostatic complications in pediatric patients undergoing extracorporeal membrane oxygenation: A retrospective cohort study
|
Drop, Joppe G.
|
|
|
|
5 |
p.
|
artikel
|
| 96 |
Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
|
Makris, Michael
|
|
|
|
5 |
p.
|
artikel
|
| 97 |
Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors
|
Spyropoulos, Alex C.
|
|
|
|
5 |
p.
|
artikel
|
| 98 |
Venous thromboembolism in critically Ill patients with COVID‐19: Results of a screening study for deep vein thrombosis
|
Longchamp, Alban
|
|
|
|
5 |
p. 842-847
|
artikel
|
| 99 |
Venous thromboembolism research priorities: A scientific statement from the American Heart Association and the International Society on Thrombosis and Haemostasis
|
Cushman, Mary
|
|
|
|
5 |
p. 714-721
|
artikel
|
| 100 |
What is the diameter of a fibrin fiber?
|
Belcher, Heather A.
|
|
|
|
5 |
p.
|
artikel
|
Tijdschrift beschrijving